{{Rsnum
|rsid=7857730
|Gene=JAK2
|Chromosome=9
|position=5084049
|Orientation=plus
|GMAF=0.3843
|Gene_s=JAK2
|Assembly=GRCh37.p5
|GenomeBuild=37.3
|dbSNPBuild=135
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}
{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 26.2 | 49.2 | 24.6
| HCB | 33.3 | 48.9 | 17.8
| JPT | 18.2 | 54.5 | 27.3
| YRI | 1.6 | 17.5 | 81.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 33.3 | 48.9 | 17.8
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=22205606
|Title=JAK2 and STAT3 polymorphisms in a Han Chinese Population with Behcet's disease
}}{{PMID Auto
|PMID=18239666
|Title=Association of common JAK2 variants with body fat, insulin sensitivity and lipid profile.
|OA=1
}}

{{PMID Auto
|PMID=20627814
|Title=Analysis of JAK2 and STAT3 polymorphisms in patients with ankylosing spondylitis in Chinese Han population.
}}
{{PMID Auto
|PMID=23611997
|Title=JAK1, but not JAK2 and STAT3, confers susceptibility to Vogt-Koyanagi-Harada (VKH) syndrome in a Han Chinese population
}}